Medtech companies are increasingly positive about macro trends amid the easing of supply and inflation headwinds in some areas and the anticipated improvement of staffing issues, according to analysts at RBC Capital Markets.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,